Literature DB >> 12656452

Apolipoprotein epsilon4 allele frequency in young Africans of Ugandan descent versus African Americans.

Floyd Willis1, Neill Graff-Radford, Martin Pinto, LaShaune Lawson, Jennifer Adamson, Dawn Epstein, Francine Parfitt, Mike Hutton, Peter C O'Brien.   

Abstract

Through its role in lipid metabolism, Apolipoprotein epsilon4 (ApoE4) may affect "brain repair" in stroke, brain hemorrhage, Alzheimer's disease, and other brain injury syndromes for which African Americans may have greater morbidity and mortality. Cross-cultural evaluations of these and other genetic factors may provide insight on possible ethnic differences in risk of morbidity to acute central nervous system (CNS) injury and chronic neurodegenerative processes. As an initial step toward expanding knowledge of ApoE allele frequencies for persons of African descent, we compared ApoE genotype of a group of 70 young Ugandans to 59 (subset of a larger group of 342 African Americans of all ages) age-matched African Americans and to published frequencies for Caucasians and Asians. We found that the ApoE4 and epsilon2 alleles are more frequent in Ugandans (U) than Caucasians (C) or Asians (A) with corresponding alleles showing significant elevations of epsilon2 (U 15.71%, C 8.40%, A 4.20%) and 14 (U 25%, C 13.70%, A 8.90%) (p < .001). Comparing the differences between Ugandans and age-appropriate African Americans (AA) was not statically significant, but this outcome may be due to small sample size. These results provide the only published ApoE frequencies for Ugandans and the complete set of data provides the largest published community group of ApoE frequencies for African Americans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656452      PMCID: PMC2594366     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  29 in total

1.  Is the apoE4 allele an independent predictor of coronary events?

Authors:  A Scuteri; A J Bos; A B Zonderman; L J Brant; E G Lakatta; J L Fleg
Journal:  Am J Med       Date:  2001-01       Impact factor: 4.965

2.  Prevalence of coronary artery disease, ischemic stroke, peripheral arterial disease, and coronary revascularization in older African-Americans, Asians, Hispanics, whites, men, and women.

Authors:  J Ness; W S Aronow
Journal:  Am J Cardiol       Date:  1999-10-15       Impact factor: 2.778

3.  Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans.

Authors:  A Loktionov; H Vorster; I K O'Neill; T Nell; S A Bingham; S A Runswick; J H Cummings
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

4.  Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients.

Authors:  P B Gorelick; J Brody; D Cohen; S Freels; P Levy; W Dollear; H Forman; Y Harris
Journal:  Arch Neurol       Date:  1993-07

5.  Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world.

Authors:  L U Gerdes; I C Klausen; I Sihm; O Faergeman
Journal:  Genet Epidemiol       Date:  1992       Impact factor: 2.135

Review 6.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

Review 7.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

8.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.

Authors:  D M Hallman; E Boerwinkle; N Saha; C Sandholzer; H J Menzel; A Csázár; G Utermann
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

9.  Genetic studies of human apolipoproteins. VII. Population distribution of polymorphisms of apolipoproteins A-I, A-II, A-IV, C-II, E, and H in Nigeria.

Authors:  B Sepehrnia; M I Kamboh; L L Adams-Campbell; M Nwankwo; R E Ferrell
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

10.  Gallstone cholesterol content is related to apolipoprotein E polymorphism.

Authors:  T Juvonen; K Kervinen; M I Kairaluoma; L H Lajunen; Y A Kesäniemi
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  6 in total

1.  Frequency of APOE, MTHFR and ACE polymorphisms in the Zambian population.

Authors:  Masharip Atadzhanov; Mwila H Mwaba; Patrice N Mukomena; Shabir Lakhi; Peter Mwaba; Sruti Rayaprolu; James F Meschia; Owen A Ross
Journal:  BMC Res Notes       Date:  2014-03-28

2.  Distribution of APOE gene polymorphism in the Chinese Uyghur children & its association with urolithiasis.

Authors:  Yuanni Huang; Mian Bao; Caixia Liu; Shukai Zheng; Taifeng Du; Kusheng Wu
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

3.  Apolipoprotein E Genetic Variation and Its Association With Cognitive Function in Rural-Dwelling Older South Africans.

Authors:  Cassandra C Soo; Meagan T Farrell; Stephen Tollman; Lisa Berkman; Almut Nebel; Michèle Ramsay
Journal:  Front Genet       Date:  2021-10-14       Impact factor: 4.772

4.  Apolipoprotein E4 is deficient in inducing macrophage ABCA1 expression and stimulating the Sp1 signaling pathway.

Authors:  Emmanuel Ugochukwu Okoro; Yanfeng Zhao; ZhongMao Guo; Lichun Zhou; Xinghua Lin; Hong Yang
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

5.  Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans.

Authors:  Laurent Larifla; Christophe Armand; Jacqueline Bangou; Anne Blanchet-Deverly; Patrick Numeric; Christiane Fonteau; Carl-Thony Michel; Séverine Ferdinand; Véronique Bourrhis; Fritz-Line Vélayoudom-Céphise
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

6.  Integrated care pathways for Black persons with traumatic brain injury: a protocol for a critical transdisciplinary scoping review.

Authors:  Samira Omar; LLana James; Angela Colantonio; Stephanie A Nixon
Journal:  Syst Rev       Date:  2020-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.